首页> 美国卫生研究院文献>The Cochrane Database of Systematic Reviews >Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo anti‐interleukin‐5 or anti‐immunoglobulin‐E agents for children and adults with asthma

【2h】

Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo anti‐interleukin‐5 or anti‐immunoglobulin‐E agents for children and adults with asthma

机译：儿童哮喘和成人哮喘的抗白介素13和抗白介素4药物与安慰剂抗白细胞介素5或抗免疫球蛋白E药物的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of anti‐interleukin‐13 or anti‐interleukin‐4 agents, compared with placebo, anti‐Immunoglobulin E agents, or anti‐interleukin‐5 agents, for the treatment of children, adolescents, or adults with asthma.

机译：这是Cochrane评估（干预）的方案。目的如下：为了评估抗白细胞介素13或抗白细胞介素4药物与安慰剂，抗免疫球蛋白E药物或抗白细胞介素5药物相比的疗效和安全性，青少年或成人哮喘。

著录项

期刊名称 The Cochrane Database of Systematic Reviews
作者
Michaela Edwards; Andrew Gallagher; Parameswaran Nair; Stewart Drew; Aashish Vyas; Rashmi Sharma; Paul A Marsden; David JW Evans;
展开▼
作者单位

展开▼
年(卷),期 -1(2018),1
年度 -1
页码 CD012929
总页数 13
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease [J] . Macaluso Fabio Salvatore, Orlando Ambrogio, Cottone Mario Nature reviews Cancer . 2019,第2期

机译：克罗恩病中抗白细胞介素-12和抗白细胞介素-23剂
2. Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease [J] . Macaluso Fabio Salvatore, Orlando Ambrogio, Cottone Mario Expert opinion on biological therapy . 2019,第1a6期

机译：抗白细胞介素-12和克罗恩病中的抗白细胞介素-23剂
3. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis [J] . Margreet Kloppenburg, Charles Peterfy, Ida K Haugen, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第3期

机译：Lutikizumab，抗白细胞介素-1α和抗白细胞介素-1β双可变域免疫球蛋白，腐蚀手骨关节炎患者的相IIA，安慰剂对照，随机研究
4. Leaveraging heat shock protein analogues to induce the expression of Interleukin 10. Smart design of emerging anti-inflammatory biomaterials [C] . Mariagemiliana Dessi, Louise Topping, Matteo Santin, World biomaterials congress . 2016

机译：来福热休克蛋白类似物诱导白介素10的表达。新兴抗炎生物材料的智能设计
5. Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents [D] . Doshi, Arpit. 2019

机译：基于嘧啶的杂环作为潜在抗癌剂的设计与合成，具有组合化疗潜力或靶向一种碳代谢抑制和抗机会性药物
6. Phase IIa placebo-controlled randomised study of lutikizumab an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin in patients with erosive hand osteoarthritis [O] . Margreet Kloppenburg, Charles Peterfy, Ida K Haugen, -1

机译：IIa期安慰剂对照的鲁替珠单抗抗白细胞介素-1α和抗白细胞介素-1β双可变域免疫球蛋白的随机研究用于患有腐蚀性手部骨关节炎的患者
7. Faculty Opinions recommendation of Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. [O] . Tonia Vincent 2019

机译：患有腐蚀手骨关节炎患者的患者IIA，抗白细胞介素-1α和抗白细胞介素-1β双可变域免疫球蛋白的IIA，安慰剂对照，随机研究的建议。

Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo anti‐interleukin‐5 or anti‐immunoglobulin‐E agents for children and adults with asthma

摘要

著录项

相似文献

相关主题

期刊订阅